Ubs Group Ag Fortress Biotech, Inc. Transaction History

Ubs Group Ag

  • $397 Billion
  • Q1 2024

Shares

26 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2023

Nov 09, 2023
BUY
$0.28 - $0.65 $6,370 - $14,788
22,751 Added 252788.89%
22,760 $6,000
Q2 2023

Aug 11, 2023
SELL
$0.49 - $0.82 $2,006 - $3,357
-4,094 Reduced 99.78%
9 $0
Q1 2023

May 12, 2023
BUY
$0.65 - $1.1 $2,661 - $4,503
4,094 Added 45488.89%
4,103 $3,000
Q4 2022

Feb 08, 2023
SELL
$0.48 - $0.88 $1,023 - $1,876
-2,132 Reduced 99.58%
9 $0
Q3 2022

Nov 10, 2022
BUY
$0.79 - $22.0 $1,691 - $47,102
2,141 New
2,141 $2,000
Q2 2022

Aug 10, 2022
SELL
$0.8 - $1.5 $1,079 - $2,023
-1,349 Closed
0 $0
Q1 2022

May 16, 2022
SELL
$1.24 - $2.75 $25,834 - $57,293
-20,834 Reduced 93.92%
1,349 $2,000
Q4 2021

Feb 14, 2022
BUY
$2.42 - $3.65 $52,956 - $79,872
21,883 Added 7294.33%
22,183 $56,000
Q3 2021

Nov 15, 2021
SELL
$2.82 - $3.7 $38,459 - $50,460
-13,638 Reduced 97.85%
300 $1,000
Q2 2021

Aug 13, 2021
SELL
$3.5 - $5.48 $8,169 - $12,790
-2,334 Reduced 14.34%
13,938 $50,000
Q1 2021

May 12, 2021
BUY
$3.16 - $4.89 $4,149 - $6,420
1,313 Added 8.78%
16,272 $58,000
Q4 2020

Feb 11, 2021
BUY
$2.2 - $4.45 $29,629 - $59,932
13,468 Added 903.29%
14,959 $47,000
Q3 2020

Nov 12, 2020
SELL
$2.62 - $4.78 $53,526 - $97,655
-20,430 Reduced 93.2%
1,491 $6,000
Q2 2020

Jul 31, 2020
BUY
$1.83 - $3.16 $38,285 - $66,110
20,921 Added 2092.1%
21,921 $59,000
Q4 2019

Feb 14, 2020
SELL
$1.25 - $2.57 $62,500 - $128,499
-50,000 Reduced 98.04%
1,000 $3,000
Q3 2019

Nov 14, 2019
BUY
$1.26 - $1.96 $62,392 - $97,055
49,518 Added 3341.3%
51,000 $72,000
Q2 2019

Aug 14, 2019
BUY
$1.43 - $1.94 $689 - $935
482 Added 48.2%
1,482 $3,000
Q1 2019

May 14, 2019
SELL
$0.94 - $2.47 $12,360 - $32,478
-13,149 Reduced 92.93%
1,000 $2,000
Q4 2018

Feb 14, 2019
BUY
$0.57 - $1.53 $2,107 - $5,656
3,697 Added 35.37%
14,149 $12,000
Q3 2018

Nov 14, 2018
BUY
$1.44 - $3.13 $7,367 - $16,013
5,116 Added 95.88%
10,452 $17,000
Q2 2018

Aug 14, 2018
BUY
$2.92 - $5.1 $5,898 - $10,302
2,020 Added 60.92%
5,336 $16,000
Q1 2018

May 15, 2018
BUY
$3.42 - $5.35 $2,729 - $4,269
798 Added 31.69%
3,316 $16,000
Q4 2017

Feb 14, 2018
SELL
$3.26 - $4.84 $7,419 - $11,015
-2,276 Reduced 47.48%
2,518 $10,000
Q3 2017

Nov 14, 2017
BUY
$3.83 - $4.89 $6,495 - $8,293
1,696 Added 54.74%
4,794 $21,000
Q2 2017

Aug 14, 2017
SELL
N/A
-40,277 Reduced 92.86%
3,098 $15,000
Q1 2017

Nov 14, 2017
BUY
N/A
43,375
43,375 $160,000

Others Institutions Holding FBIO

# of Institutions
6
Shares Held
1.01M
Call Options Held
0
Put Options Held
0
View Full List

About Fortress Biotech, Inc.

FBIO Quotes by TradingView
  • Ticker FBIO
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 107,735,000
  • Market Cap $194M
  • Description
  • Fortress Biotech, Inc., a biopharmaceutical company, develops and commercializes pharmaceutical and biotechnology products. The company markets dermatology products, such as Ximino capsules to treat only inflammatory lesions of non-nodular moderate to severe acne vulgaris; Targadox for severe acne; Exelderm cream for ringworm and jock itch sympt...
More about FBIO
Track This Portfolio

Track Ubs Group Ag Portfolio

Follow Ubs Group Ag and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Ubs Group Ag, based on Form 13F filings with the SEC.

News

Stay updated on Ubs Group Ag with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email